COVID-19 Patients | Days after onset | ||||
---|---|---|---|---|---|
0–30 | 31–60 | 61–90 | 91–120 |  > 120 | |
Ground-glass opacities (GGO) | 88.66% (352/397) | 90.76% (275/303) | 91.41% (149/163) | 75.58% (65/86) | 65.31% (32/49) |
Meshwork | 30.73% (122/397) | 13.53% (41/303) | 14.11% (23/163) | 6.98% (6/86) | 10.20% (5/49) |
Parenchymal bands | 82.37% (327/397) | 94.72% (287/303) | 95.71% (156/163) | 97.67% (84/86) | 93.88% (46/49) |
Irregular interface | 26.45% (105/397) | 25.41% (77/303) | 25.15% (41/163) | 22.09% (19/86) | 28.57% (14/49) |
Traction bronchiectasis | 5.54% (22/397) | 14.52% (44/303) | 19.02% (31/163) | 16.28% (14/86) | 14.29% (7/49) |